This season was certainly an career outlier for Montgomery, but it would be risky for Arizona to take a chance with him in the rotation if they want to compete. “Monty” is definitely a valuable ...
Kerr’s willingness to go 13 deep into his rotation landed fine when they were blowing teams out and piling up a 12-3 record through 15 games. It’s tough for players to grumble and pundits to ...
We're nearing the end of Phase 5 of the MCU which marks the midway point of The Multiverse Saga, following the releases of Agatha All Along and Deadpool & Wolverine. If that all sounds confusing ...
The Los Angeles Angels agreed to a deal with left-handed pitcher Yusei Kikuchi to a three-year, $63 million contract on Monday, their second addition to the starting rotation this offseason.
The Giants’ 2024 rotation didn’t live up to its preseason hype — or Farhan Zaidi’s assessment of being the “best rotation in baseball”. Despite the additions of Blake Snell ...
Af­ter the FDA re­ject­ed Out­look Ther­a­peu­tics’ oph­thalmic for­mu­la­tion of be­va­cizum­ab last year, the ex­per­i­men­tal ther­a­py has now failed a late-stage study ...
OpenAI has cut off testing access to its Sora video generation platform after a group of artists briefly shared their own early access in a publicly usable webpage Tuesday. The group, going by the ...
A group of aggrieved artists and early testers of OpenAI’s unreleased text-to-video tool Sora leaked access to the new model in an act of protest after they claimed to have been used for ...
The Red Sox are looking to improve their rotation this winter but it remains to be seen how exactly that will play out. They have previously been connected to top free agents such as Corbin Burnes ...
A storm has been brewing in the AI landscape following the unauthorized leak of access to OpenAI’s groundbreaking Sora model, which was triggered by concerns around alleged exploitation and ...
Two tiragolumab combinations have now failed phase 3 NSCLC trials, and the drug candidate has also flunked a late-stage test in small cell lung cancer. There remain opportunities to redeem TIGIT ...